SK17722002A3 - Nenukleozidové inhibítory reverznej transkriptázy, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Nenukleozidové inhibítory reverznej transkriptázy, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number
SK17722002A3
SK17722002A3 SK1772-2002A SK17722002A SK17722002A3 SK 17722002 A3 SK17722002 A3 SK 17722002A3 SK 17722002 A SK17722002 A SK 17722002A SK 17722002 A3 SK17722002 A3 SK 17722002A3
Authority
SK
Slovakia
Prior art keywords
mmol
ethyl
solution
dihydro
methyl
Prior art date
Application number
SK1772-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Bruno Simoneau
Original Assignee
Boehringer Ingelheim (Canada) Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim (Canada) Ltd. filed Critical Boehringer Ingelheim (Canada) Ltd.
Publication of SK17722002A3 publication Critical patent/SK17722002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
SK1772-2002A 2000-06-16 2001-06-14 Nenukleozidové inhibítory reverznej transkriptázy, farmaceutický prostriedok s ich obsahom a ich použitie SK17722002A3 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21232900P 2000-06-16 2000-06-16
US25663800P 2000-12-18 2000-12-18
PCT/CA2001/000890 WO2001096338A1 (en) 2000-06-16 2001-06-14 Non-nucleoside reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
SK17722002A3 true SK17722002A3 (sk) 2003-06-03

Family

ID=26907019

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1772-2002A SK17722002A3 (sk) 2000-06-16 2001-06-14 Nenukleozidové inhibítory reverznej transkriptázy, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (36)

Country Link
US (1) US6420359B1 (ru)
EP (1) EP1294720B1 (ru)
JP (1) JP3923894B2 (ru)
KR (1) KR20030017540A (ru)
CN (1) CN1178939C (ru)
AR (1) AR028958A1 (ru)
AT (1) ATE322492T1 (ru)
AU (2) AU7037001A (ru)
BG (1) BG107348A (ru)
BR (1) BR0102377A (ru)
CA (1) CA2411766C (ru)
CZ (1) CZ20024114A3 (ru)
DE (1) DE60118560T2 (ru)
DK (1) DK1294720T3 (ru)
EA (1) EA005598B1 (ru)
EE (1) EE200200690A (ru)
ES (1) ES2261433T3 (ru)
HK (1) HK1057558A1 (ru)
HR (1) HRP20021003A2 (ru)
HU (1) HUP0301105A2 (ru)
IL (1) IL152819A0 (ru)
MX (1) MXPA02012205A (ru)
MY (1) MY130375A (ru)
NO (1) NO323830B1 (ru)
NZ (1) NZ523549A (ru)
PE (1) PE20020083A1 (ru)
PL (1) PL360370A1 (ru)
PT (1) PT1294720E (ru)
SA (1) SA01220202B1 (ru)
SK (1) SK17722002A3 (ru)
TW (1) TWI270547B (ru)
UA (1) UA74834C2 (ru)
UY (1) UY26767A1 (ru)
WO (1) WO2001096338A1 (ru)
YU (1) YU94202A (ru)
ZA (1) ZA200209807B (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716836B2 (en) 2001-03-22 2004-04-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6673791B2 (en) 2001-07-30 2004-01-06 Boehringer Ingelheim (Canada) Ltd. Non-nucleoside reverse transcriptase inhibitors
US6706706B2 (en) * 2002-03-27 2004-03-16 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6806265B2 (en) * 2002-05-16 2004-10-19 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
US6759533B2 (en) * 2002-06-28 2004-07-06 Boehringer Ingelheim Pharmaceuticals, Inc. Process and intermediates for making non-nucleoside HIV-1 reverse transcriptase inhibitors
US7642277B2 (en) 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
EA200500894A1 (ru) * 2002-12-16 2006-02-24 Бёрингер Ингельхайм Интернациональ Гмбх Применение комбинации, содержащей ненуклеозидный ингибитор обратной транскриптазы (нниот) в сочетании с ингибитором цитохрома p450, таким как протеазные ингибиторы
WO2004087140A1 (en) * 2003-03-27 2004-10-14 Boehringer Ingelheim International Gmbh Antiviral combination of a dipyridodiazepinone and a further antiretroviral compound
US7309700B2 (en) * 2004-04-02 2007-12-18 Boehringer Ingelheim International Gmbh Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-dipyrido[3,2-b:2′,3′-e] [1,4]diazepin-6-one
US20060025480A1 (en) 2004-08-02 2006-02-02 Boehringer Ingelheim International Gmbh Benzoic acid derivatives as non nucleoside reverse transcriptase inhibitors
US7151174B2 (en) * 2004-11-05 2006-12-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for making a non-nucleoside HIV-1 reverse transcriptase inhibitor
US7282583B2 (en) * 2005-12-05 2007-10-16 Boehringer Ingelheim International Gmbh Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one
EP2085390A1 (en) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
MX2011010582A (es) * 2009-04-09 2011-10-19 Boehringer Ingelheim Int Inhibidores de la replicacion del vih.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5705499A (en) * 1995-10-06 1998-01-06 Boehringer Ingelheim Pharmaceuticals, Inc. 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6H-dipyrido 3,2-B:2',3'-e! 1!diazepines and their use in the treatment of HIV-1 infection

Also Published As

Publication number Publication date
HRP20021003A2 (en) 2005-02-28
ATE322492T1 (de) 2006-04-15
DE60118560D1 (de) 2006-05-18
AU7037001A (en) 2001-12-24
MXPA02012205A (es) 2003-09-10
IL152819A0 (en) 2003-06-24
UY26767A1 (es) 2002-01-31
NO323830B1 (no) 2007-07-09
ES2261433T3 (es) 2006-11-16
EE200200690A (et) 2004-06-15
SA01220202B1 (ar) 2006-09-05
NO20025844L (no) 2002-12-05
ZA200209807B (en) 2003-10-16
PL360370A1 (en) 2004-09-06
MY130375A (en) 2007-06-29
BR0102377A (pt) 2002-02-19
CN1436189A (zh) 2003-08-13
JP2004502787A (ja) 2004-01-29
US6420359B1 (en) 2002-07-16
EA200201255A1 (ru) 2003-06-26
CA2411766A1 (en) 2001-12-20
NZ523549A (en) 2004-08-27
DE60118560T2 (de) 2006-09-28
PE20020083A1 (es) 2002-02-28
JP3923894B2 (ja) 2007-06-06
CZ20024114A3 (cs) 2003-04-16
DK1294720T3 (da) 2006-07-31
HUP0301105A2 (hu) 2003-08-28
KR20030017540A (ko) 2003-03-03
EP1294720B1 (en) 2006-04-05
AR028958A1 (es) 2003-05-28
BG107348A (bg) 2004-06-30
CN1178939C (zh) 2004-12-08
HK1057558A1 (en) 2004-04-08
YU94202A (sh) 2005-11-28
NO20025844D0 (no) 2002-12-05
US20020028807A1 (en) 2002-03-07
AU2001270370B2 (en) 2006-08-03
EA005598B1 (ru) 2005-04-28
TWI270547B (en) 2007-01-11
WO2001096338A1 (en) 2001-12-20
PT1294720E (pt) 2006-06-30
UA74834C2 (en) 2006-02-15
EP1294720A1 (en) 2003-03-26
CA2411766C (en) 2006-05-23

Similar Documents

Publication Publication Date Title
US5908841A (en) 5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e!azepine-6-ones and their use in the prevention of treatment of HIV infection
EP1554276B1 (en) Non-nucleoside reverse transcriptase inhibitors
AU2007275816A1 (en) 1-hydroxy naphthyridine compounds as anti-HIV agents
SK17722002A3 (sk) Nenukleozidové inhibítory reverznej transkriptázy, farmaceutický prostriedok s ich obsahom a ich použitie
AU2001270370A1 (en) Non-nucleoside reverse transcriptase inhibitors
RU2142464C1 (ru) 2-гетероарил-5,11-дигидро-6н-дипиридо[3,2-b:2',3'-e][1,4] диазепин-6-оны, их фармацевтически приемлемые соли, фармацевтическая композиция, обладающая ингибирующей активностью в отношении обратной транскриптазы вич-1
EP1414820B1 (en) Non-nucleoside reverse transcriptase inhibitors
EP1373267B1 (en) Non-nucleoside reverse transcriptase inhibitors
EP1495024B1 (en) Dipyridodiazepinones as reverse transcriptase inhibitors
EP1655300A1 (en) Non-nucleoside reverse transcriptase inhibitors
WO1999007380A1 (en) 5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e] AZEPIN-6-ONES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
HU214595B (hu) Eljárás 5,11-dihidro-6H-dipirido [3,2-b:2',3'-e][1,4] diazepinek és ezeket tartalmazó gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
FC9A Refused patent application